✦ LIBER ✦

T-48 Efficacy and safety of intravenous silibinin in patients with HCV recurrence on the graft after liver transplantation (LT): a prospective, randomized, double-blind, placebo-controlled pilot study

✍ Scribed by Rendina, M.; D'Amato, M.; Castellaneta, A.; Castellaneta, N.M.; Brambilla, N.; Giacovelli, G.; Rovati, L.; Rizzi, S.F.; Zappimbulso, M.; Bringiotti, R.; Di Leo, A.

Book ID: 123390857
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 55 KB
Volume: 45
Category: Article
ISSN: 1590-8658
DOI: 10.1016/S1590-8658(13)60084-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

176 PROSPECTIVE, RANDOMIZED, DOUBLE-BLIN

176 PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PILOT STUDY EVALUATING EFFICACY AND SAFETY OF INTRAVENOUS SILIBININ IN PATIENTS WITH HCV RECURRENCE ON THE GRAFT AFTER LIVER TRANSPLANTATION

✍ Rendina, M.; D'Amato, M.; Castellaneta, A.; Castellaneta, N.M.; Brambilla, N.; G 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Rationale and design of the EMBRACE STEM

Rationale and design of the EMBRACE STEMI Study: A phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction

✍ Chakrabarti, Anjan K.; Feeney, Kristin; Abueg, Cassandra; Brown, David A.; Czyz, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 322 KB